High-dose cisplatin concurrent to conventionally delivered radiotherapy is associated with unacceptable toxicity in unresectable, non-metastatic stage IV head and neck squamous cell carcinoma-Reference-Cited by-同舟云学术

High-dose cisplatin concurrent to conventionally delivered radiotherapy is associated with unacceptable toxicity in unresectable, non-metastatic stage IV head and neck squamous cell carcinoma

Published:2007-07-21 Issue:12 Volume:264 Page:
ISSN:0937-4477
Container-title:European Archives of Oto-Rhino-Laryngology
language:en
Short-container-title:Eur Arch Otorhinolaryngol

Author:

de Castro Gilberto,Snitcovsky Igor Moisés Longo,Gebrim Eloísa Maria Mello Santiago,Leitão Glauber Moreira,Nadalin Wladimir,Ferraz Alberto Rossetti,Federico Miriam Hatsue Honda

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Otorhinolaryngology

Link

http://link.springer.com/content/pdf/10.1007/s00405-007-0395-9.pdf

Reference39 articles.

1. Adelstein DJ, Li Y, Adams GL, Wagner H Jr, Kish JA, Ensley JF, Schuller DE, Forastiere AA (2003) An Intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol 21:92–98

2. Cooper JS, Farnan NC, Asbell SO, Rotman M, Marcial V, Fu KK, McKenna WG, Emami B (1996) Recursive partitioning analysis of 2105 patients treated in Radiation Therapy Oncology Group studies of head and neck cancer. Cancer 77:1905–1911

3. Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG, Morrow M (2002) AJCC cancer staging handbook. 6th edn. Springer, New York

4. Pignon JP, Bourhis J, Domenge C, Designé L (2000) Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. Lancet 355:949–955

5. Available at http://www.fosp.saude.sp.gov.br , accessed in June 23rd, 2006

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of Acute Side Effects Among 3D-Concurrent Radiotherapy With Cisplatin-Treated Head and Neck Cancer Patients;Cureus;2023-08-28

2. A New Prognostic Instrument for Predicting the Probability of Completion of Cisplatin during Chemoradiation for Head and Neck Cancer;Journal of Personalized Medicine;2023-07-10

3. First Results of Concurrent Chemoradiation with Two Courses of 5 × 25 mg/m2 Cisplatin for Locally Advanced Head and Neck Cancer;Journal of Personalized Medicine;2023-06-16

4. Pharmacoeconomic Appraisal of Treating Head and Neck Cancer with Various Chemotherapy and Chemoirradiation Regimens Using Branded and Jan-aushadhi Drugs in India;Indian Journal of Otolaryngology and Head & Neck Surgery;2023-04-08

5. Comparison of Two Cisplatin Regimens for Chemoradiation in Patients With Squamous-cell Carcinoma of the Head and Neck;Anticancer Research;2023-01-25